Ephedra Supplement Safety To Be Revisited At Senate Subcommittee Hearing
This article was originally published in The Tan Sheet
Executive Summary
An "independent analysis" of 14,700 ephedra-related adverse event reports received by Metabolife International will be discussed by the Senate Governmental Affairs/Oversight of Government Management Subcommittee during a hearing slated for Oct. 8
You may also be interested in...
Metabolife Federal Probe Spurs Release Of Ephedrine Complaint Records
An FDA task force will review the 13,000 ephedrine alkaloid patient complaint records Metabolife is releasing in response to publicity surrounding a criminal investigation into whether the company lied about its knowledge of adverse events
Ephedra “Imminent Hazard” Declaration Sought By Sen. Durbin
Sen. Dick Durbin (D-Ill.) is pressing HHS Secretary Tommy Thompson to take immediate action against the sale of ephedra weight-loss dietary supplements by declaring the herbal ingredient an "imminent hazard.
Herbal Regulatory Category Creation At FDA Suggested By Sen. Durbin
Sen. Dick Durbin (D-Ill.) is exploring the concept of a new regulatory scheme for dietary supplements that would create a separate regulatory category for herbal products